Stuart Head

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial

Thuijs D, Habib R, Head S, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik J, Kappetein A

May 20, 2020 | 10.4244/EIJ-D-19-00417

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A

May 20, 2018 | 10.4244/EIJ-D-17-00620

A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team

Amrane H, Porta F, Van Boven A, Kappetein A, Head S

June 2, 2017 | 10.4244/EIJ-D-16-00103

Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial

Milojevic M, Head S, Andrinopoulou E, Serruys P, Mohr F, Tijssen J, Kappetein A

May 15, 2017 | 10.4244/EIJ-D-16-00745

VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies

Erlebach M, Head S, Mylotte D, Leon M, Serruys P, Kappetein A, Martucci G, Généreux P, Windecker S, Lange R, Piazza N

June 20, 2016 | 10.4244/EIJV12I3A60

CABG, stents, or hybrid procedures for left main disease?

Kappetein A, Head S

May 19, 2015 | 10.4244/EIJV11SVA25

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein A, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

TAVI at institutions without cardiovascular surgery departments: why?

Mylotte D, Head S, Kappetein A, Piazza N

September 28, 2014 | 10.4244/EIJV10I5A95

Patient selection for TAVI in 2014: is there a justification for treating low- or intermediate-risk patients? The surgeon’s view

Kappetein A, Osnabrugge R, Head S

September 27, 2014 | 10.4244/EIJV10SUA2

Transcatheter aortic valve replacement and vascular complications definitions

Van Mieghem N, Généreux P, van der Boon R, Kodali S, Head S, Williams M, Daneault B, Kappetein A, de Jaegere P, Leon M, Serruys P

March 20, 2014 | 10.4244/EIJV9I11A222

Surgical or transcatheter mitral valve intervention: complex disease requires complex decisions

Head S, van Leeuwen W, Van Mieghem N, Kappetein A

February 20, 2014 | 10.4244/EIJV9I10A191

Transcatheter aortic valve implantation by the surgeon: technique, tips and tricks for the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System

Amrane H, Porta F, Van Boven A, Hofma S, Head S, Kappetein A

February 7, 2014

Tools and Techniques - Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System

Amrane H, Porta F, Van Boven A, Hofma S, Head S, Kappetein A

September 27, 2013 | 10.4244/EIJV9I5A103

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

Kappetein A, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M

November 20, 2012 | 10.4244/EIJV8I7A121

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

Van Mieghem N, Head S, van der Boon R, Piazza N, de Jaegere P, Carrel T, Kappetein A, Lange R, Walther T, Windecker S, Van Es G-A, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A40

What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement?

Kappetein A, Head S, Treede H, Reichenspurner H, Mohr F, Walther T

December 30, 2011 | 10.4244/EIJV7I8A143

Transcatheter aortic valve implantation after PARTNER: what is up next?

Head S, Kappetein A

November 15, 2010

Stuart Head

Latest news